IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Transdermal Methimazole in the Treatment of 16 Cats with Hyperthyroidism

Author(s):  Wingate Gary

Issue:  Sep/Oct 2002 - Veterinary Compounding
View All Articles in Issue

Abstract:  The efficacy of transdermal methimazole in 16 cats with hyperthyroidism was evaluated. During the 2-year study period, 15 of the 16 treated cats exhibited a significant decrease in serum T4 value, and in 1 cat the serum T4 level increased. The mean total dose, which was administered once or twice daily, was 6.53 mg/day (range, 5 to 12.5 mg). An initial recheck of the T4 level was conducted after an average of 7.4 weeks (range, 4 to 38 wk) of treatment with transdermal methimazole. The cats that responded to therapy showed a mean reduction in the T4 level from 10.82 mg/dL (range, 4.2 to 24 mg/dL) to 2.76 mg/dL (range, 0.3 to 5.2 mg/dL). The only adverse effect of treatment (an increase in the blood urea nitrogen [BUN] level) developed in only one cat (6%) within 30 days of the initiation of therapy; that patient was scheduled to undergo reevaluation of the BUN level after 2 months. The increase in the BUN level in that cat, which was 16 years of age, was probably due to an unmasking of preexisting senile renal dysfunction rather than treatment-induced toxicity. The most common symptoms of the 16 cats studied before they underwent treatment with transdermal methimazole were weight loss, which was associated with increased appetite in some cats, and heart murmur. Other symptoms included vomiting, vocalization, and lethargy. The results of the study indicate that transdermal methimazole is effective in blocking excess thyroid hormone secretion in most cats and that it is a relatively safe antithyroid medication therapy for use in cats.

Related Keywords: Feline hyperthyroidism, use of methimazole, Hyperthyroidism, methimazole use in cats, Transdermal methimazole, use in feline hyperthyroidism

Related Categories: VETERINARY

Printer-Friendly Version




Download in electronic PDF format for $35

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Transdermal Methimazole in the Treatment of 16 Cats with Hyperthyroidism Wingate Gary Sep/Oct 2002 344-345 Buy
Veterinary Transdermal Medications: A to Z Davidson Gigi S Mar/Apr 2003 106-113 Buy
Understanding Feline Hyperthyroidism Davidson Gigi S Sep/Oct 2003 345-347 Buy
Stability of Methimazole in Poloxamer Lecithin Organogel to Determine Beyond-Use Date Pignato Alyssa, Pankaskie Marvin, Birnie Christine Nov/Dec 2010 522-525 Buy
Evaluating Transdermal Medication Forms for Veterinary Patients, Part 3: Methimazole Davidson Gigi S Jul/Aug 2001 282-283 Buy
Methimazole 5 mg/0.1 mL in Pluronic Lecithin Organogel Gel, Veterinary Allen Loyd V Jr Jan/Feb 2019 56 Buy
Methimazole 10-mg/mL Oral Liquid, Veterinary Allen Loyd V Jr May/Jun 2005 229 Buy
Feline Ophthalmic Disease: Feline Herpesvirus and Systemic Hypertension Davidson Michael G Mar/Apr 2001 92-94 Buy
Case Report: Management of Secondary Hypertension in a Feline with the Use of Transdermal Prazosin Rudner Shara, Browne Paul Nov/Dec 2010 488-491 Buy
Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases Mixon William, Helms Scott R Sep/Oct 2008 392-397 Buy